For HIV-1–negative, at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1. See full Indication.

Frequently Asked Questions
Find answers to common questions that may arise when getting started with APRETUDE in your practice.
Please speak with your Territory Account Manager (TAM) if you have any additional questions while prescribing or administering APRETUDE. Contact us